![]() ![]() High blood sugar-increased thirst, increased urination, dry mouth, fruity breath odor or Redness, warmth, swelling, oozing, or severe irritation of any treated skin īlurred vision, tunnel vision, eye pain, or seeing halos around lights ![]() Triamcinolone topical may cause serious side effects. Get emergency medical help if you have signs of an allergic reaction: hives difficult breathing swelling of your face, lips, tongue, or throat. Store at room temperature away from moisture and heat. You should stop using this medicine once your symptoms are controlled. A mouth ulcer should improve within 1 week of using triamcinolone dental paste. Follow your doctor's instructions.Ĭall your doctor if your symptoms do not improve, or if they get worse. ![]() Triamcinolone dental paste is usually applied at bedtime and/or after meals. The dab will form a thin film that should be left in place for several hours. To use the dental paste, press a small dab onto the mouth ulcer but do not rub in the medicine. If you are treating the diaper area, do not use plastic pants or tight-fitting diapers. Covering treated areas can increase the amount of medicine absorbed through your skin and may cause harmful effects. Do not apply this medicine over a large area of skin unless your doctor has told you to.ĭo not cover the treated skin area with a bandage or other covering unless your doctor tells you to. Wash your hands before and after using triamcinolone topical, unless you are using this medicine to treat the skin on your hands.Īpply a thin layer of medicine to the affected skin. Triamcinolone dental paste is applied directly onto an ulcer inside the mouth and left in place. Triamcinolone topical cream, lotion, ointment, or spray is for use only on the skin. If a favorable response does not occur promptly, the corticosteroid should be discontinued until the infection has been adequately controlled.Follow all directions on your prescription label and read all medication guides or instruction sheets. In the presence of dermatological infections, the use of an appropriate antifungal or antibacterial agent should be instituted. If irritation develops, topical corticosteroids should be discontinued and appropriate therapy instituted. Children may absorb proportionally larger amounts of topical corticosteroids and thus be more susceptible to systemic toxicity (see Infrequently, signs and symptoms of steroid withdrawal may occur, requiring supplemental systemic corticosteroids. Recovery of HPA axis function is generally prompt and complete upon discontinuation of the drug. If HPA axis suppression is noted, an attempt should be made to withdraw the drug, to reduce the frequency of application, or to substitute a less potent steroid. Therefore, patients receiving a large dose of a potent topical steroid applied to a large surface area or under an occlusive dressing should be evaluated periodically for evidence of HPA axis suppression by using the urinary free cortisol and ACTH stimulation tests. Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing’s syndrome, hyperglycemia, and glucosuria in some patients.Ĭonditions which augment systemic absorption include the application of the more potent steroids, use over large surface areas, prolonged use, and the addition of occlusive dressings. Some of the topical corticosteroids and their metabolites are also excreted into the bile. Corticosteroids are metabolized primarily in the liver and are then excreted by the kidneys. Corticosteroids are bound to plasma proteins in varying degrees. Once absorbed through the skin, topical corticosteroids are handled through pharmacokinetic pathways similar to systemically administered corticosteroids. Thus, occlusive dressings may be a valuable therapeutic adjunct for treatment of resistant dermatoses (seeĭOSAGE AND ADMINISTRATION). Occlusive dressings substantially increase the percutaneous absorption of topical corticosteroids. Inflammation and/or other disease processes in the skin increase percutaneous absorption. Topical corticosteroids can be absorbed from normal intact skin. The extent of percutaneous absorption of topical corticosteroids is determined by many factors including the vehicle, the integrity of the epidermal barrier, and the use of occlusive dressings. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |